Irvine, CA, United States of America

Ina Mustafaj

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Ina Mustafaj

Introduction

Ina Mustafaj is a notable inventor based in Irvine, California. She has made significant contributions to the field of medical technology, particularly in the development of innovative therapeutic implants. With a total of two patents to her name, her work focuses on improving treatment options for ocular diseases.

Latest Patents

Ina Mustafaj's latest patents include the development of bioerodible cross-linked hydrogel implants. These implants are designed for the sustained release of therapeutic agents from a hydrogel matrix. The hydrogel matrix is a cross-linked bioerodible polyethylene glycol (PEG) hydrogel that contains a therapeutic complex dispersed within it. This complex may include a therapeutic agent associated with mesoporous silica particles. The composite implant is intended for delivery or implantation into the eye of a patient. It aims to treat various ocular diseases, including neovascular age-related macular degeneration (AMD), diabetic macular edema, and macular edema following retinal vein occlusion.

Career Highlights

Ina Mustafaj is currently associated with Dose Medical Corporation, where she continues to innovate in the medical field. Her work has the potential to significantly impact the treatment of ocular diseases, providing new hope for patients suffering from these conditions.

Collaborations

Ina collaborates with Patrick Michael Hughes, contributing to the advancement of medical technologies through their combined expertise.

Conclusion

Ina Mustafaj's innovative work in developing bioerodible hydrogel implants showcases her commitment to improving patient care in the field of ophthalmology. Her contributions are paving the way for new therapeutic options in treating ocular diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…